LuciDac (Dacomitinib)

Inquire / Price
  • Model Number:
    RL3120250101
  • Brand Name:
    LuciDac
  • Origin:
    Generic drug,Laos
  • Small Orders:
    Small batches also available
  • Tags:
Inquire Now Link

Poster
  • Details
  • Description
  • Packaging Size
    30t/bottle
  • Strength
    15mg&45mg
  • Compositon
    Dacomitinib
  • Treatment
    EGFR exon 19 deletions or exon 21 (L858R) substitution mutations non-small cell lung cancer (NSCLC)
  • Form
    Tablet
  • Brand
    LuciDac
  • Quantity Unit
    15mg*30T/Bottle&45mg*30T/Bottle
  • Manufacturer
    Lucius Pharmaceuticals (Lao) Co.,Ltd

INDICATIONS AND USAGE

Dacomitinib is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.

DOSAGE AND ADMINISTRATION

Recommended Dosage: 45 mg orally once daily with or without food.


Link

Poster

Top